CAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Thursday reported third-quarter profit of $1.37 billion.
On a per-share basis, the Cambridge, Britain-based company said it had profit of 44 cents. Earnings, adjusted for non-recurring costs, came to 87 cents per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 80 cents per share.
The pharmaceutical posted revenue of $11.49 billion in the period, also topping Street forecasts. Four analysts surveyed by Zacks expected $11.44 billion.
Astrazeneca shares have declined slightly more than 6% since the beginning of the year. The stock has climbed nearly 4% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AZN at https://www.zacks.com/ap/AZN